Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-03-028979
Filing Date
2003-12-19
Accepted
2003-12-19 16:30:55
Documents
10
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 10-K a03-3659_110k.htm 10-K 484359
3 EX-10.31 a03-3659_1ex10d31.htm EX-10.31 382591
4 EX-10.35 a03-3659_1ex10d35.htm EX-10.35 82121
5 EX-13.1 a03-3659_1ex13d1.htm EX-13.1 1671724
6 EX-23.1 a03-3659_1ex23d1.htm EX-23.1 4892
7 EX-31.1 a03-3659_1ex31d1.htm EX-31.1 10708
8 EX-31.2 a03-3659_1ex31d2.htm EX-31.2 10922
9 EX-32.1 a03-3659_1ex32d1.htm EX-32.1 7454
10 GRAPHIC g36591beimage002.jpg GRAPHIC 43798
11 GRAPHIC g36591beimage004.jpg GRAPHIC 26806
  Complete submission text file 0001104659-03-028979.txt   2727961
Mailing Address 8899 UNIVERSITY CENTER LANE STE 400 SAN DIEGO CA 92122
Business Address 8899 UNIVERSITY CTR LANE STE 400 SAN DIEGO CA 92122 8584534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-14430 | Film No.: 031065586
SIC: 2833 Medicinal Chemicals & Botanical Products